nach oben

Journal of Gastroenterology

Erschienen in:

01.06.2009 | Review

Epidemiology and clinical characteristics of GERD in the Japanese population

verfasst von: Yasuhiro Fujiwara, Tetsuo Arakawa

Erschienen in: Journal of Gastroenterology | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

We reviewed articles on the epidemiology and clinical characteristics of gastroesophageal reflux disease (GERD) in Japan to clarify these features of GERD in this country. Although the definition of GERD depends on the individual study, the prevalence of GERD has been increasing since the end of the 1990s. The reasons for the increase in the prevalence of GERD may be due to increases in gastric acid secretion, a decrease in the Helicobacter pylori infection rate, more attention being paid to GERD, and advances in the concept of GERD. More than half of GERD patients had non-erosive reflux disease, and the majority (87%) of erosive esophagitis was mild type, such as Los Angeles classification grade A and grade B. There were several identified risk factors, such as older age, obesity, and hiatal hernia. In particular, mild gastric atrophy and absence of H. pylori infection influence the characteristics of GERD in the Japanese population. We also discuss GERD in the elderly; asymptomatic GERD; the natural history of GERD; and associations between GERD and peptic ulcer disease and H. pylori eradication. We examined the prevalence of GERD in patients with specific diseases, and found a higher prevalence of GERD, compared with that in the general population, in patients with diabetes mellitus, those with obstructive sleep apnea syndrome, and those with bronchial asthma. We provide a comprehensive review of GERD in the Japanese population and raise several clinical issues.

Kinoshita Y, Adachi K, Fujishiro H. Therapeutic approaches to reflux disease, focusing on acid secretion. J Gastroenterol. 2003;38(suppl 15):13–9.PubMed

Osugi H, Higashino M, Kaseno S, Takada N, Takemura M, Ueno M, et al. Ambulatory intraesophageal bilirubin monitoring in Japanese patients with gastroesophageal reflux. J Gastroenterol. 2002;37:697–702.PubMedCrossRef

Mittal RK. Pathophysiology of gastroesophageal reflux: motility factors. J Gastroenterol. 2003;38(suppl 15):7–12.PubMed

Iwakiri K, Sugiura T, Hayashi Y, Kotoyori M, Kawakami A, Makino H, et al. Esophageal motility in Japanese patients with Barrett’s esophagus. J Gastroenterol. 2003;38:1036–41.PubMedCrossRef

Yoshida N, Yoshikawa T. Defense mechanism of the esophageal mucosa and esophageal inflammation. J Gastroenterol. 2003;38(suppl 15):31–4.PubMed

Miwa H, Minoo T, Hojo M, Yaginuma R, Nagahara A, Kawabe M, et al. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Aliment Pharmacol Ther. 2004;20(suppl 1):112–7.PubMedCrossRef

Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007;42:1–15.PubMedCrossRef

Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol. 2003;38(suppl 15):25–30.PubMed

Fujimoto K. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther. 2004;20(suppl 8):5–8.PubMedCrossRef

10.

Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol. 2006;4:398–407.PubMedCrossRef

11.

Kouzu T, Hishikawa E, Watanabe Y, Inoue M, Satou T. Epidemiology of GERD in Japan (in Japanese). Nippon Rinsho. 2007;65:791–4.PubMed

12.

Kusano M, Ino K, Yamada T, Kawamura O, Toki M, Ohwada T, et al. Interobserver and intraobserver variation in endoscopic assessment of GERD using the “Los Angeles” classification. Gastrointest Endosc. 1999;49:700–4.PubMedCrossRef

13.

Hoshihara Y, Hashimoto M. Endoscopic classification of reflux esophagitis (in Japanese). Nippon Rinsho. 2000;58:1808–12.PubMed

14.

Amano Y, Ishimura N, Furuta K, Okita K, Masaharu M, Azumi T, et al. Interobserver agreement on classifying endoscopic diagnoses of nonerosive esophagitis. Endoscopy. 2006;38:1032–5.PubMedCrossRef

15.

Miwa H, Yokoyama T, Hori K, Tanimura M, Honda Y, Isozaki K, et al. Interobserver agreement in endoscopic evaluation of reflux esophagitis using a modified Los Angeles classification incorporating grades N and M: a validation study in a cohort of Japanese endoscopists. Dis Esophagus. 2008;21:355–63.PubMedCrossRef

16.

Endo M, Kobayashi S, Suzuki H, Takemoto T, Nakayama K. Diagnosis of early esophageal cancer. Endoscopy. 1971;2:61–6.CrossRef

17.

Makuuchi H. Clinical study of sliding esophageal hernia with special reference to the diagnostic criteria and classification of the severity of the disease (in Japanese). Nippon Shokakibyo Gakkai Zasshi. 1982;79:1557–67.PubMed

18.

Yoshimori M, Yamashita S, Suzuki S, Fukutomi H, Oguro Y, Doi H, et al. Esophagitis, peptic ulcer, and gastric acidity (in Japanese). Gastroenterol Endosc. 1975;17:714–8.

19.

Furuya S, Kodama T, Takaaki J, Fukui Y, Fujita S, Maeda T, et al. Epidemiology of reflux esophagitis (in Japanese). Shoukakika. 1994;19:357–65.

20.

Tsuchiya H, Takasu S. Epidemiology (in Japanese). In: Tsuneoka K, editor. Reflux esophagitis. Tokyo: Bunkoudou; 1988. p. 101–9.

21.

Sakurai Y. Retrospective analysis of 2431 cases of gastroesophageal reflux disease (GERD) diagnosed by panendoscopy (in Japanese). Stomach Intest. 1999;34:963–9.

22.

Kuma E, Kato T, Sakanishi Y, Nakagawa H, Kagaya T, Tomori G, et al. A clinical study of the reflux esophagitis (in Japanese). Tama Symp J Gastroenterol. 1991;5:48–53.

23.

Yamaguchi Y, Sakurai Y, Ohyama T, Yamamura F, Terada M, Itoh M, et al. Clinical epidemiological study of GERD with Los-Angeles classification (in Japanese). Gastroenterol Endosc. 1998;40:1138–44.

24.

Keida Y, Yamaguchi Y, Shinjou M, Shimabukuro Y, Shinoura Y, Kikuchi K. Study of reflux esophagitis and hiatal hernia at Okinawa prefectural Chubu Hospital (in Japanese). Okinawa Igakukai Zasshi. 2005;43:34–8.

25.

Arizawa K, Kawaguchi S, Yonezawa T, Doi M, Mizuno W, Mautmoto T, et al. Endoscopic and clinical evaluation of reflux esophagitis (in Japanese). Gastroenterol Endosc. 1992;34:1008–16.

26.

Yamaguchi M, Iwakiri R, Yamaguchi K, Mizuta T, Shimoda R, Sakata Y, et al. Bleeding and stenosis caused by reflux esophagitis was not common in emergency endoscopic examinations: a retrospective patient chart review at a single institution in Japan. J Gastroenterol. 2008;43:265–9.PubMedCrossRef

27.

Maekawa T, Kinoshita Y, Okada A, Fukui H, Waki S, Hassan S, et al. Relationship between severity and symptoms of reflux oesophagitis in elderly patients in Japan. J Gastroenterol Hepatol. 1998;13:927–30.PubMedCrossRef

28.

Tomiyama R, Miyasato S, Chinen T, Maeda K, Fukuchi A, Sugama R, et al. Clinical study of reflux esophagitis at Miyako area in Okinawa (in Japanese). Okinawa Igakkai Zassi. 2001;39:19–21.

29.

Furukawa N, Iwakiri R, Koyama T, Okamoto K, Yoshida T, Kashiwagi Y, et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol. 1999;34:441–4.PubMedCrossRef

30.

Okamoto K, Iwakiri R, Mori M, Hara M, Oda K, Danjo A, et al. Clinical symptoms in endoscopic reflux esophagitis: evaluation in 8031 adult subjects. Dig Dis Sci. 2003;48:2237–41.PubMedCrossRef

31.

Sakamoto H, Goto A, Nakagawa T, Nagano K, Mihara F, Mugikura S. The study of reflux esophagitis in Hakodate district (in Japanese). Dounan Igaku Kaishi. 2001;35:364–7.

32.

Kawai T, Koguma K, Kudou T, Umezawa H, Hagiwara S, Morita S, et al. Prevalence of reflux esophagitis and study of refractory reflux esophagitis in our hospital (in Japanese). Tama Symp J Gastroenterol. 2001;15:22–9.

33.

Iwakiri K, Tanaka Y, Hayashi Y, Kotoyori M, Kawami N, Kawakami A, et al. Association between reflux esophagitis and/or hiatus hernia and gastric mucosal atrophy level in Japan. J Gastroenterol Hepatol. 2007;22:2212–6.PubMedCrossRef

34.

Inamori M, Togawa J, Nagase H, Abe Y, Umezawa T, Nakajima A, et al. Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification. J Gastroenterol Hepatol. 2003;18:172–6.PubMedCrossRef

35.

Inaba T, Kawai K, Kobara H, Miyatake H, Morimoto N, Hiratsuka I, et al. The usefulness of a structured questionnaire (QUEST) in the assessment of gastroesophageal reflux disease (in Japanese). J New Rem Clin. 1999;48:1277–89.

36.

Ohta M, Kikuchi T, Shigematsu K, Suzuki T, Nakamura A, Okamoto F, et al. A study on endoscopic findings of reflux esophagitis and Barrett’s esophagus (in Japanese). Tama Symp J Gastroenterol. 2001;15:10–3.

37.

Morichika K, Hashimoto T, Kusano M, Hosoda S, Kuramoto T, Tamura K, et al. Association of obesity with reflux esophagitis (in Japanese). Juntendo Med J. 2005;51:83–9.

38.

Sekiguchi T, Ohwada T, Hagihara O, Kimura M. Prevalence of reflux esophagitis in 2000 (in Japanese). Nippon Rinshou Naika Ikai Zassi. 2005;20:393–402.

39.

Fujiwara Y, Higuchi K, Shiba M, Watanabe T, Tominaga K, Oshitani N, et al. Association between gastroesophageal flap valve, reflux esophagitis, Barrett’s epithelium, and atrophic gastritis assessed by endoscopy in Japanese patients. J Gastroenterol. 2003;38:533–9.PubMed

40.

Nagoshi A, Zai H, Harasawa S. Epidemiology and pathogenesis of reflux esophagitis (in Japanese). Clin Gastroenterol. 2004;7:441–4.

41.

Amano Y, Komazawa Y, Ishimura N, Fujishiro H, Ishihara S, Adachi K, et al. Prevalence of reflux esophagitis in patients with duodenal ulcer and gastric ulcer. J Gastroenterol. 2003;38:514–5.PubMedCrossRef

42.

Shimazu T, Matsui T, Furukawa K, Oshige K, Mitsuyasu T, Kiyomizu A, et al. A prospective study of the prevalence of gastroesophageal reflux disease and confounding factors. J Gastroenterol. 2005;40:866–72.PubMedCrossRef

43.

Ohara S, Kouzu T, Kawano T, Kusano M. Nationwide epidemiological survey regarding heartburn and reflux esophagitis in Japanese (in Japanese). Nippon Shokakibyo Gakkai Zasshi. 2005;102:1010–24.PubMed

44.

Nagoshi A, Kusano M, Harasawa S. Epidemiology and pathogenesis of reflux esophagitis (in Japanese). Clin Gastroenterol. 2007;10:431–5.

45.

Sakaguchi M, Oka H, Hashimoto T, Asakuma Y, Takao M, Gon G, et al. Obesity as a risk factor for GERD in Japan. J Gastroenterol. 2008;43:57–62.PubMedCrossRef

46.

Amano K, Adachi K, Katsube T, Watanabe M, Kinoshita Y. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly. J Gastroenterol Hepatol. 2001;16:132–6.PubMedCrossRef

47.

Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, et al. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut. 2001;49:335–40.PubMedCrossRef

48.

Fujishiro H, Adachi K, Kawamura A, Katsube T, Ono M, Yuki M, et al. Influence of Helicobacter pylori infection on the prevalence of reflux esophagitis in Japanese patients. J Gastroenterol Hepatol. 2001;16:1217–21.PubMedCrossRef

49.

Uetake T, Shibata N, Osawa A, Ishikawa M, Kobayashi M, Kojima Y, et al. Changes in incidence of gastroesophageal reflux disease (GERD) over 10 years in an aging district and its characteristics (in Japanese). Shoukakika. 2000;30:139–43.

50.

Sekiguchi T, Horikoshi T. Pathogenesis and treatment of gastroesophageal reflux disease (in Japanese). Jpn Med J. 1997;3830:1–5.

51.

Moki F, Kusano M, Mizuide M, Shimoyama Y, Kawamura O, Takagi H, et al. Association between reflux oesophagitis and features of the metabolic syndrome in Japan. Aliment Pharmacol Ther. 2007;26:1069–75.PubMed

52.

Nakamura T, Kitahara F, Ohtsuka H, Kojima Y, Sato T, Enomoto N, et al. Prevalence and relationship of Barrett’s mucosa, reflux esophagitis, hiatal hernia and atrophic gastritis (in Japanese). Shoukakiaka. 2005;41:10–5.

53.

Furuta K, Adachi K, Arima N, Yagi J, Tanaka S, Miyaoka Y, et al. Study of arteriosclerosis in patients with hiatal hernia and reflux esophagitis. J Gastroenterol Hepatol. 2007;22:1732–6.PubMedCrossRef

54.

Yagi N, Arai M, Fujimoto S. Importance of lifestyle advice in the management of endoscopically negative gastroesophageal reflux disease patients in Japan (in Japanese). Shoukakaika. 2006;43:194–201.

55.

Kobayashi T, Yoshino J, Wakabayashi T, Inui K, Okushima K, Miyoshi H, et al. Study of the characteristics of gastroesophageal reflux disease (NERD, in particular) as discovered in a mass survey (in Japanese). J Gastroenterol Cancer Screen. 2006;44:283–91.

56.

Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol. 2005;40:1005–9.PubMedCrossRef

57.

Funatsu K, Tomai K, Kurihara K, Homma M, Yamashita T, Hosoai K, et al. A clinical study on erosive and non-erosive gastroesophageal reflux disease in health check-up subjects (in Japanese). Ningen Dock. 2008;22:811–7.

58.

Miwa H, Sasaki M, Furuta T, Koike T, Habu Y, Ito M, et al. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan. Aliment Pharmacol Ther. 2007;26:69–77.PubMed

59.

Nozu TH. Clinical characteristics of asymptomatic esophagitis. J Gastroenterol. 2008;43:27–31.PubMedCrossRef

60.

Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.PubMedCrossRef

61.

Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1963;3:87–97.

62.

Watanabe S, Hojo M, Nagahara A. Metabolic syndrome and gastrointestinal diseases. J Gastroenterol. 2007;42:267–74.PubMedCrossRef

63.

Sugiyama T, Nishikawa K, Komatsu Y, Ishizuka J, Mizushima T, Kumagai A, et al. Attributable risk of H. pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-H. pylori ulcers? Dig Dis Sci. 2001;46:307–10.PubMedCrossRef

64.

Asaka M, Sugiyama T, Nobuta A, Kato M, Takeda H, Graham DY. Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter. 2001;6:294–9.PubMedCrossRef

65.

Manabe N, Haruma K, Hata J, Kamada T, Kusunoki H. Differences in recognition of heartburn symptoms between Japanese patients with gastroesophageal reflux, physicians, nurses, and healthy lay subjects. Scand J Gastroenterol. 2008;43:398–402.PubMedCrossRef

66.

Wada T, Sasaki M, Kataoka H, Tanida S, Itoh K, Ogasawara N, et al. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005;21(suppl 2):2–9.PubMedCrossRef

67.

Fujiwara Y, Higuchi K, Nebiki H, Chono S, Uno H, Kitada K, et al. Famotidine versus omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005;21(suppl 2):10–8.PubMedCrossRef

68.

Joh T, Miwa H, Higuchi K, Shimatani T, Manabe N, Adachi K, et al. Validity of endoscopic classification of nonerosive reflux disease. J Gastroenterol. 2007;42:444–9.PubMedCrossRef

69.

Hongo M, Kinoshita Y, Shimozuma K, Kumagai Y, Sawada M, Nii M. Psychometric validation of the Japanese translation of the quality of life in reflux and dyspepsia questionnaire in patients with heartburn. J Gastroenterol. 2007;42:807–15.PubMedCrossRef

70.

Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–9.PubMedCrossRef

71.

Nagano K, Kubo M, Goto M, Tatsuta M, Iishi H, Kanda T, et al. The diagnosis of GERD: a study of a questionnaire (QUEST) for patients complaining of upper gastrointestinal symptoms (in Japanese). J New Rem Clin. 1998;47:841–51.

72.

Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39:888–91.PubMedCrossRef

73.

Shimoyama Y, Kusano M, Sugimoto S, Kawamura O, Maeda M, Minashi K, et al. Diagnosis of gastroesophageal reflux disease using a new questionnaire. J Gastroenterol Hepatol. 2005;20:643–7.PubMedCrossRef

74.

Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol. 1999;231(suppl):20–8.CrossRef

75.

Kato K, Kodama T, Fujita S, Kashima K, Sano A, Sakagami K. Epidemiology of gastroesophageal reflux disease: a questionnaire-based survey of heartburn symptoms. In: Matsuo Y, Kasuya Y, Muto T, Tsuchiya M, editors. Gastrointestinal function. Regulation and disturbance, vol. 15. Tokyo: Excepta Medica; 1977. p. 69–75.

76.

Fujiwara Y, Higuchi K, Watanabe Y, Shiba M, Watanabe T, Tominaga K, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol. 2005;20:26–9.PubMedCrossRef

77.

Watanabe Y, Fujiwara Y, Shiba M, Watanabe T, Tominaga K, Oshitani N, et al. Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol. 2003;38:807–11.PubMedCrossRef

78.

Kubota E, Tanida S, Sasaki M, Kataoka H, Oshima T, Ogasawara N, et al. Contribution of Helicobacter pylori infection and obesity on heartburn in a Japanese population. J Clin Biochem Nutr. 2006;39:168–73.CrossRef

79.

Yamagishi H, Koike T, Ohara S, Kobayashi S, Ariizumi K, Abe Y, et al. Prevalence of gastroesophageal reflux symptoms in a large unselected general population in Japan. World J Gastroenterol. 2008;14:1358–64.PubMedCrossRef

80.

Sudou H, Tanaka Y, Kurai A, Namiki K, Miyake Y, Yamada F, et al. The usefulness of QUEST questionnaire and PPI test in the assessment of GERD in clinical practice (in Japanese). Nippon Rinsho Naika Ikai Zassi. 2007;22:71–5.

81.

Watanabe T, Urita Y, Sugimoto M, Miki K. Gastroesophageal reflux disease symptoms are more common in general practice in Japan. World J Gastroenterol. 2007;13:4219–23.PubMed

82.

Galmiche JP, Clouse RE, Bálint A, Cook IJ, Kahrilas PJ, Paterson WG, et al. Functional esophageal disorders. Gastroenterology. 2006;130:1459–65.PubMedCrossRef

83.

Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, Chiba T. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut. 1997;41:452–8.PubMedCrossRef

84.

Fujiwara Y, Higuchi K, Shiba M, Yamamori K, Watanabe Y, Sasaki E, et al. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Am J Gastroenterol. 2005;100:754–8.PubMedCrossRef

85.

Urita Y, Nishino S, Koyama H, Kondo E, Yamada S, Ozaki M, et al. Reflux esophagitis in the elderly (in Japanese). J Geriatr Gastroenterol. 1997;9:85–9.

86.

Urita Y, Miki K. Reflux esophagitis in the elderly (in Japanese). Clinica. 1998;25:257–61.

87.

Tanimura H, Kubo M, Kawano S. Clinical study of reflux esophagitis in the elderly (in Japanese). Ther Res. 1999;20:2297–9.

88.

Watabe H, Sasaki S, Andachi H, Sasaki H. Examination of patients aged 80 years and older with reflux esophagitis at Hirose Municipal Hospital (in Japanese). Nippon Kourei Shoukaki Igakkai Zassi. 2001;3:92–7.

89.

http://www.mhlw.go.jp/toukei/saikin/hw/life/life06/index.html.

90.

Fujimoto K, Iwakiri R, Okamoto K, Oda K, Tanaka A, Tsunada S, et al. Characteristics of gastroesophageal reflux disease in Japan: increased prevalence in elderly women. J Gastroenterol. 2003;38(suppl 15):3–6.PubMed

91.

Kusano M, Hashizume K, Ehara Y, Shimoyama Y, Kawamura O, Mori M. Size of hiatus hernia correlates with severity of kyphosis, not with obesity, in elderly Japanese women. J Clin Gastroenterol. 2008;42:345–50.PubMedCrossRef

92.

Furuya S, Yamashita S, Takaaki J, Fukui Y, Fukuda S, Kodama T. The characteristics of reflux esophagitis of the aged group (in Japanese). Shoukakika. 1992;16:15–23.

93.

Sakakibara K, Harasawa S, Miwa T. Appropriate therapy and characteristics of reflux esophagitis in elderly patients (in Japanese). J Geriatr Gastroenterol. 1994;6:107–12.

94.

Tada N, Nagai T, Shintani E, Miyairi Y. A clinical study on reflux esophagitis in the aged. Tama Symp J Gastroenterol. 1991;5:54–8.

95.

Kusano M, Kouzu T, Kono T, Ohara S. The prevalence of hiatus hernia in the Japanese (in Japanese). Gastroenterol Endosc. 2005;47:962.

96.

Ohara S, Sekine H, Iijima K, Moriyama S, Nakayama Y, Kinpara T, et al. Gastric mucosal atrophy and prevalence of Helicobacter pylori in reflux esophagitis of the elderly (in Japanese). Nippon Shoukakibyou Gakkaishi. 1996;93:235–9.

97.

Miyamoto M, Haruma K, Kuwabara M, Nagano M, Okamoto T, Tanaka M. High incidence of newly-developed gastroesophageal reflux disease in the Japanese community: a 6-year follow-up study. J Gastroenterol Hepatol. 2008;23:393–7.PubMedCrossRef

98.

Azumi T, Adachi K, Arima N, Tanaka S, Yagi J, Koshino K, et al. Five-year follow-up study of patients with reflux symptoms and reflux esophagitis in annual medical check-up field. Intern Med. 2008;47:691–6.PubMedCrossRef

99.

Kawanishi M. Will symptomatic gastroesophageal reflux disease develop into reflux esophagitis? J Gastroenterol. 2006;41:440–3.PubMedCrossRef

100.

Manabe N, Yoshihara M, Sasaki A, Tanaka S, Haruma K, Chayama K. Clinical characteristics and natural history of patients with low-grade reflux esophagitis. J Gastroenterol Hepatol. 2002;17:949–54.PubMedCrossRef

101.

Yoshida T, Sakaki N, Aonuma K, Ogino M, Mon Y, Shinkai Y, et al. Gastric mucosa in patients with reflux esophagitis (in Japanese). Gastroenterol Endosc. 1981;23:775–80.

102.

Takaaki J, Furuya S, Takamasu M, Atsumi M, Ebisui S, Fukumitsu S, et al. Endoscopic study of reflux esophagitis with reference to the course of endoscopical findings (in Japanese). Gastroenterol Endosc. 1990;32:1097–103.

103.

Nakajima S, Hattori T. Active and inactive gastroesophageal reflux diseases related to Helicobacter pylori therapy. Helicobacter. 2003;8:279–93.PubMedCrossRef

104.

Hamada H, Haruma K, Mihara M, Kamada T, Yoshihara M, Sumii K, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther. 2000;14:729–35.PubMedCrossRef

105.

Murai T, Miwa H, Ohkura R, Iwazaki R, Nagahara A, Sato K, et al. The incidence of reflux oesophagitis after cure of Helicobacter pylori in a Japanese population. Aliment Pharmacol Ther. 2000;14(suppl 1):161–5.PubMedCrossRef

106.

Yachida S, Saito D, Kozu T, Gotoda T, Inui T, Fujishiro M, et al. Endoscopically demonstrable esophageal changes after Helicobacter pylori eradication in patients with gastric disease. J Gastroenterol Hepatol. 2001;16:1346–52.PubMedCrossRef

107.

Koike T, Ohara S, Sekine H, Iijima K, Kato K, Toyota T, et al. Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis. Aliment Pharmacol Ther. 2001;15:813–20.PubMedCrossRef

108.

Fukuchi T, Ashida K, Yamashita H, Kiyota N, Tsukamoto R, Takahashi H, et al. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer. J Gastroenterol. 2005;40:350–60.PubMedCrossRef

109.

Inoue H, Imoto I, Taguchi Y, Kuroda M, Nakamura M, Horiki N, et al. Reflux esophagitis after eradication of Helicobacter pylori is associated with the degree of hiatal hernia. Scand J Gastroenterol. 2004;39:1061–5.PubMedCrossRef

110.

Yamamori K, Fujiwara Y, Shiba M, Watanabe T, Tominaga K, Oshitani N, et al. Prevalence of symptomatic gastro-oesophageal reflux disease in Japanese patients with peptic ulcer disease after eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 2004;20(suppl 1):107–11.PubMedCrossRef

111.

Sasaki A, Haruma K, Manabe N, Tanaka S, Yoshihara M, Chayama K. Long-term observation of reflux oesophagitis developing after Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2003;17:1529–34.PubMedCrossRef

112.

Miwa H, Sugiyama Y, Ohkusa T, Kurosawa A, Hojo M, Yokoyama T, et al. Improvement of reflux symptoms 3 years after cure of Helicobacter pylori infection: a case-controlled study in the Japanese population. Helicobacter. 2002;7:219–24.PubMedCrossRef

113.

Ishiki K, Mizuno M, Take S, Nagahara Y, Yoshida T, Yamamoto K, et al. Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease. Clin Gastroenterol Hepatol. 2004;2:474–9.PubMedCrossRef

114.

Koike T, Ohara S, Sekine H, Iijima K, Abe Y, Kato K, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut. 2001;49:330–4.PubMedCrossRef

115.

Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.PubMedCrossRef

116.

Kirizuka K, Nishizaki H, Yamamoto K, Ueshima M, Ohya M, Moridera K, et al. Correlation between GERD and DM patients (in Japanese). Kobe City Hosp Bull. 2003;42:39–42.

117.

Nishida T, Tsuji S, Tsujii M, Arimitsu S, Sato T, Haruna Y, et al. Gastroesophageal reflux disease related to diabetes: analysis of 241 cases with type 2 diabetes mellitus. J Gastroenterol Hepatol. 2004;19:258–65.PubMedCrossRef

118.

Akiyama T, Tomisu C, Gouhara S, Miyajima Y, Arikawa M, Tashiro M, et al. The prevalence of upper gastrointestinal (GI) symptoms in diabetic patients based on QUEST score (in Japanese). Dig Absorpt. 2004;27:46–9.

119.

Hisano N, Kojima Y, Kanno R, Ono M, Yoshitsugu M, Hiyoshi T. Evaluation of gastroesophageal reflux disease in patients with diabetes mellitus using questionnaire (in Japanese). Naika. 2006;98:927–9.

120.

Kase H, Hattori Y, Sato N, Banba N, Kasai K. Symptoms of gastroesophageal reflux in diabetes patients. Diabetes Res Clin Pract. 2008;79:e6–7.PubMedCrossRef

121.

Ariizumi K, Koike T, Ohara S, Inomata Y, Abe Y, Iijima K, et al. Incidence of reflux esophagitis and H. pylori infection in diabetic patients. World J Gastroenterol. 2008;14:3212–7.PubMedCrossRef

122.

Kinekawa F, Kubo F, Matsuda K, Fujita Y, Tomita T, Uchida Y, et al. Relationship between esophageal dysfunction and neuropathy in diabetic patients. Am J Gastroenterol. 2001;96:2026–32.PubMedCrossRef

123.

Kinekawa F, Kubo F, Matsuda K, Kobayashi M, Furuta Y, Fujita Y, et al. Esophageal function worsens with long duration of diabetes. J Gastroenterol. 2008;43:338–44.PubMedCrossRef

124.

Kinekawa F, Kubo F, Matsuda K, Kobayashi M, Furuta Y, Yamanouchi H, et al. Is the questionnaire for the assessment of gastroesophageal reflux useful for diabetic patients? Scand J Gastroenterol. 2005;40:1017–20.PubMedCrossRef

125.

Akatsu T, Yoshida M, Kawachi S, Tanabe M, Shimazu M, Kumai K, et al. Consequences of living-donor liver transplantation for upper gastrointestinal lesions: high incidence of reflux esophagitis. Dig Dis Sci. 2006;51:2108–22.

126.

Kakizaki S, Sohara N, Sato K, Nakajima Y, Tsunoda N, Takagi H, et al. Gastroesophageal reflux disease in chronic liver disease using frequency scale for the symptoms of GERD (in Japanese). Jpn J Clin Exp Med. 2006;83:419–22.

127.

Ueda A, Enjoji M, Kato M, Yamashita N, Horikawa Y, Tajiri H, et al. Frequency of gastroesophageal reflux disease (GERD) as a complication in patients with chronic liver diseases: estimation of frequency scale for the symptoms of GERD (in Japanese). Fukuoka Igakkaishi. 2007;98:373–8.

128.

Abe H, Yoshizawa K, Kitahara T, Mitobe J, Hirohama K, Aizawa R, et al. Significance of the gastroesophageal reflux disease (GERD) screening with the frequency scale for the symptoms of GERD (FSSG) in patients with chronic liver disease (in Japanese). Shoukakika. 2007;44:421–5.

129.

Suzuki K, Suzuki K, Koizumi K, Ichimura H, Oka S, Takada H, et al. Measurement of serum branched-chain amino acids to tyrosine ratio level is useful in a prediction of a change of serum albumin level in chronic liver disease. Hepatol Res. 2008;38:267–72.PubMedCrossRef

130.

Nishiguchi S, Shiomi S, Kurooka H, Iwata Y, Sasaki N, Tamori A, et al. Randomized trial assessing gastric emptying in patients with chronic hepatitis C during interferon-alpha or -beta therapy and effect of cisapride. Dig Dis Sci. 2002;47:73–8.PubMedCrossRef

131.

Okamoto E, Amano Y, Fukuhara H, Furuta K, Miyake T, Sato S, et al. Does gastroesophageal reflux have an influence on bleeding from esophageal varices? J Gastroenterol. 2008;43:803–8.PubMedCrossRef

132.

Suganuma N, Shigedo Y, Adachi H, Watanabe T, Kumano-Go T, Terashima K, et al. Association of gastroesophageal reflux disease with weight gain and apnea, and their disturbance on sleep. Psychiatry Clin Neurosci. 2001;55:255–6.PubMedCrossRef

133.

Uchiyama Y, Hayashi M, Matsui K, Hirata M, Fujita S, Konishi Y, et al. Gastroesophageal reflux disease with obstructive sleep apnea syndrome (in Japanese). Bull Fujita-Gakuen Med Soc. 2003;27:73–7.

134.

Sugai N, Suzuki J. Sleep apnea syndrome and reflux esophagitis (in Japanese). JOHNS. 2006;22:819–22.

135.

Sato H, Iwashima A, Kawabe S, Nakayama H, Yoshizawa H, Gejyo F, et al. Effect of continuous positive airway pressure on gastroesophageal reflux in sleep apnea syndrome (in Japanese). Nippon Kokyu Kanri Gakkaishi. 2005;14:491–5.

136.

Tanimura H, Imaizumi N, Watabe Y, Imamura E, Sugimoto K, Miki T, et al. Study of gastroesophageal reflux disease with sleep apnea syndrome (in Japanese). Ther Res. 2005;26:892–4.

137.

Tanaka H, Minoshima Y, Umezono K, Ito S, Kobayashi S, Nishio H. Gastroesophageal reflux disease in patients with obstructive sleep apnea syndrome by using frequency scale for the symptoms of GERD (in Japanese). Med Postgrad. 2007;45:140–4.

138.

Sato H, Iwashima A, Nakayama H, Gejyo F, Hasegawa T, Suzuki E. Diagnosis of gastroesophageal reflux disease associated with obstructive sleep apnea syndrome using the frequency scale for the symptoms of GERD and therapeutic effects of continuous positive airway pressure and rabeprazole (in Japanese). J New Rem Clin. 2008;57:1107–13.

139.

Mizuta Y, Takashima F, Shikuwa S, Ikeda S, Kohno S. Is there a specific linkage between obstructive sleep apnea syndrome and gastroesophageal reflux disease? Dig Endosc. 2006;18:88–97.CrossRef

140.

Suzuki J, Sasaki K, Adachi T, Sadaoka K, Kanai T, Seki H, et al. A study of gastroesophageal reflux by 24-h esophageal pH monitoring in patients with bronchial asthma (in Japanese). Nippon Shokakibyo Gakkai Zasshi. 1997;94:519–25.PubMed

141.

Tomioka H, Itani T, Nakase H, Sakamoto H, Fujiyama R, Ohnishi H, et al. Bronchial asthma and reflux esophagitis. A clinical study on 106 cases with bronchial asthma (in Japanese). Jpn J Chest Dis. 1999;58:829–35.

142.

Nakase H, Itani T, Mimura J, Kawasaki T, Komori H, Tomioka H, et al. Relationship between asthma and gastro-oesophageal reflux: significance of endoscopic grade of reflux oesophagitis in adult asthmatics. J Gastroenterol Hepatol. 1999;14:715–22.PubMedCrossRef

143.

Tsugeno H, Mizuno M, Fujiki S, Okada H, Okamoto M, Hosaki Y, et al. A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux. Scand J Gastroenterol. 2003;38:456–61.PubMedCrossRef

144.

Shimizu Y, Dobashi K, Kobayashi S, Ohki I, Tokushima M, Kusano M, et al. High prevalence of gastroesophageal reflux disease with minimal mucosal change in asthmatic patients. Tohoku J Exp Med. 2006;209:329–36.PubMedCrossRef

145.

Shimizu Y, Dobashi K, Kobayashi S, Ohki I, Tokushima M, Kusano M, et al. A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease. Tohoku J Exp Med. 2006;209:181–9.PubMedCrossRef

146.

Sato A, Tanifuji Y, Kobayashi H, Inoue H. Effects of proton pump inhibitor on airway hyperresponsiveness in asthmatics with gastroesophageal reflux (in Japanese). Arerugi. 2006;55:641–6.PubMed

147.

Nogami H, Kamikawaji N, Shimoda T, Shoji S, Nishima S. Gastro-esophageal reflux disease as a complication in asthmatics (in Japanese). Jpn J Chest Dis. 2007;66:684–9.

148.

Takezawa T. The relationship between bronchial asthma and gastroesophageal reflux disease (in Japanese). Teikyo Med J. 2008;31:75–86.

Titel: Epidemiology and clinical characteristics of GERD in the Japanese population
verfasst von: Yasuhiro Fujiwara
Tetsuo Arakawa
Publikationsdatum: 01.06.2009
Verlag: Springer Japan
Erschienen in: Journal of Gastroenterology / Ausgabe 6/2009
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI: https://doi.org/10.1007/s00535-009-0047-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2009

Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis

Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis

Efficacy and safety of addition of minor bloodletting (petit phlebotomy) in hepatitis C virus-infected patients receiving regular glycyrrhizin injections

Autoimmune pancreatitis in Japan: overview and perspective

Down-regulation of miR-141 in gastric cancer and its involvement in cell growth